ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,646Medicare Part D Prescriptions Filled, Including Refills

Rank: 486 out of 6969

$420K Total Retail Price of All Prescriptions

Rank: 859 out of 6969

473 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

27% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,791 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 514 374 S3 1 3
SIMVASTATIN 485 455 2 1
LISINOPRIL 449 392 3 2
LEVOTHYROXINE SODIUM 324 260 4 5
METOPROLOL TARTRATE 264 258 5 13
AMLODIPINE BESYLATE 238 222 6 4
FUROSEMIDE 228 221 7 10
HYDROCHLOROTHIAZIDE 221 142 8 8
METFORMIN HCL 167 139 9 7
LOSARTAN POTASSIUM 164 160 10 12
OMEPRAZOLE 161 126 11 6
CARVEDILOL 153 140 12 25
ALENDRONATE SODIUM 143 139 13 14
WARFARIN SODIUM 134 80 14 20
LANTUS 128 113 15 50
DONEPEZIL HCL 123 112 16 32
RAMIPRIL 122 115 17 112
ZOLPIDEM TARTRATE 119 71 18 16
RANITIDINE HCL 119 94 18 46
GABAPENTIN 117 96 20 17
TAMSULOSIN HCL 116 116 21 23
GLIMEPIRIDE 114 112 22 44
DIVALPROEX SODIUM 101 59 23 103
POTASSIUM CHLORIDE 98 77 24 30
FLUTICASONE PROPIONATE 95 73 25 24
PROAIR HFA 90 57 26 33
NIFEDIPINE ER 89 82 27 95
NOVOLOG 87 76 28 166
FLUOXETINE HCL 83 54 29 43
SPIRIVA 79 55 30 66
TRAMADOL HCL 77 74 31 27
CITALOPRAM HBR 76 37 32 34
MORPHINE SULFATE ER 72 48 S2 33 90
ATORVASTATIN CALCIUM 68 55 34 11
METHADONE HCL 67 16 S2 35 121
PANTOPRAZOLE SODIUM 65 65 36 31
LOVASTATIN 64 64 37 15
ACETAMINOPHEN-CODEINE 64 60 S3 37 73
QUETIAPINE FUMARATE 64 53 37 101
ADVAIR DISKUS 64 47 37 45
NAMENDA 60 60 41 51
IBUPROFEN 58 31 42 29
PRAVASTATIN SODIUM 58 58 42 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 41 42 28
KLOR-CON M10 57 57 45 257
METOPROLOL SUCCINATE 56 36 46 22
CARBAMAZEPINE 56 48 46 204
TRIAMCINOLONE ACETONIDE 55 46 48 55
HUMALOG 52 50 49 167
FAMOTIDINE 50 28 50 37
BENAZEPRIL HCL 50 39 50 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.